BackCyclo Therapeutics- Warrants (14/11/2025) Overview

Cyclo Therapeutics- Warrants (14/11/2025) Current Assets

Latest current assets for CYTHW: $3.3M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.26M
40.91% YoYΔ $-2.25M vs prior year quarter

Peer trimmed avg / median

Loading

Cyclo Therapeutics- Warrants (14/11/2025) Current Assets History

Loading

Cyclo Therapeutics- Warrants (14/11/2025) vs. peers: Current Assets Comparison

Loading

Cyclo Therapeutics- Warrants (14/11/2025) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cyclo Therapeutics- Warrants (14/11/2025) (CYTHW) FAQ

As of the most recent data (September 2024), CYTHW shows a current assets of $3.3M. That compares with $5.5M in the prior-year period — down 40.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTHW's current assets is now $3.3M (was $5.5M) — a 40.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclo Therapeutics- Warrants (14/11/2025) is outperforming or lagging.

Tracking CYTHW's current assets over time shows whether Cyclo Therapeutics- Warrants (14/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.3M That compares with $5.5M in the prior-year period — down 40.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Cyclo Therapeutics- Warrants (14/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $3.3M) with ownership activity and broader fundamentals.

Cyclo Therapeutics- Warrants (14/11/2025)'s current assets is $3.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.